Williams Kristen Marie 4
4 · Pacira BioSciences, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
WILLIAMS KRISTEN
Chief Administrative Officer
Transactions
- Sale
Common Stock
2022-03-21$72.67/sh−7,253$527,076→ 22,268 total - Exercise/Conversion
Common Stock
2022-03-21$38.35/sh+2,953$113,248→ 25,221 total - Exercise/Conversion
Common Stock
2022-03-21$43.54/sh+2,112$91,956→ 27,333 total - Exercise/Conversion
Common Stock
2022-03-21$47.65/sh+2,188$104,258→ 29,521 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-21−2,953→ 2,953 totalExercise: $38.35Exp: 2028-06-13→ Common Stock (2,953 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-21−2,112→ 10,560 totalExercise: $43.54Exp: 2029-06-05→ Common Stock (2,112 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-21−2,188→ 19,685 totalExercise: $47.65Exp: 2030-06-09→ Common Stock (2,188 underlying)
Footnotes (2)
- [F1]The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.